Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $57.1095 (-0.88%) ($56.8641 - $57.4549) on Thu. Oct. 6, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 0.84% (three month average) | RSI | 49 | Latest Price | $57.1095(-0.88%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | ABBV declines -0.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(61%) VYM(49%) IVE(47%) IWD(46%) SPY(46%) | Factors Impacting ABBV price | ABBV will decline at least -0.42% in a week (0% probabilities). VIXM(-18%) TLT(-14%) UUP(-9%) IPO(-4%) IGOV(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.42% (StdDev 0.84%) | Hourly BBV | 0 () | Intraday Trend | -0.5% | | | |
|
Resistance Level | $57.82 | 5 Day Moving Average | $57.36(-0.44%) | 10 Day Moving Average | $57.79(-1.18%) | 20 Day Moving Average | $57.82(-1.23%) | To recent high | -6.8% | To recent low | 0% | Market Cap | $100.757b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |